Search Results

Total: 138 , 1/14

Show Home Prev Next End page: GO

MeSH:(Platelet Aggregation Inhibitors/therapeutic use)

1.Still unsettled issue: antiplatelet therapy after stenting in patients taking oral anticoagulants.

Murat ATALAY ; Mehmet TEZCAN ; Murat YALCIN ; Zafer ISILAK ; Ejder KARDESOGLU

Chinese Medical Journal 2013;126(22):4397-4397

2.Advance on clinical applications of platelet glycoprotein IIb/IIIa receptor inhibitors.

Peng ZHOU ; Hong-Bing YAN

Chinese Journal of Cardiology 2011;39(3):274-277

3.Isolated medial rectus palsy.

Chang-Song XU ; Qi WAN ; Feng XIAO

Chinese Medical Journal 2013;126(18):3432-3432

4.Optimizing the duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents.

Ying SHEN ; Wei-Feng SHEN

Chinese Medical Journal 2015;128(6):711-713

5.Impact of genetic polymorphisms on efficacy of antiplatelet therapy.

Yi-Tong MA ; Xiang XIE

Chinese Journal of Cardiology 2011;39(7):674-676

6.Optimal management of blood disease: keeping in sight of platelet.

Chinese Journal of Hematology 2012;33(9):699-700

7.What have we learned from the expert consensus of antiplatelet therapy in cardiovascular disease?.

Chinese Journal of Cardiology 2013;41(3):179-180

8.Individualized Antiplatelet Therapy: A Long Way to Go.

Chinese Medical Journal 2018;131(12):1387-1389

9.Chinese Society of Cardiology and Chinese College of Cardiovascular Physicians Expert Consensus statement on dual antiplatelet therapy in patients with coronary artery disease.

Chinese Journal of Cardiology 2021;49(5):432-454

10.Research progress of double antithrombotic therapy in cardiovascular diseases.

Kai Lun YAN ; Xue Yan ZHAO

Chinese Journal of Cardiology 2023;51(12):1290-1294

Sort by

Result Analysis

Display Mode

Brief Abstract

Selected Records All Records

Output Records

All Records(≤500)
Selected Records
All Records on Page
Records To (≤500)

File Type

Normal
NoteExpress
Refworks
EndNote
XML

Print

Save

E-mail

Total: 138 , 1/14 Show Home Prev Next End page: GO